SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-153339
Filing Date
2021-05-06
Accepted
2021-05-06 16:28:28
Documents
5
Effectiveness Date
2021-05-06

Document Format Files

Seq Description Document Type Size
1 S-8 d924558ds8.htm S-8 49406
2 EX-5.1 d924558dex51.htm EX-5.1 12870
3 EX-23.1 d924558dex231.htm EX-23.1 1525
4 GRAPHIC g924558dsp6.jpg GRAPHIC 3266
5 GRAPHIC g924558dsp7.jpg GRAPHIC 2609
  Complete submission text file 0001193125-21-153339.txt   73186
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-255832 | Film No.: 21898266
SIC: 2834 Pharmaceutical Preparations